全文获取类型
收费全文 | 4040篇 |
免费 | 254篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 21篇 |
儿科学 | 118篇 |
妇产科学 | 93篇 |
基础医学 | 759篇 |
口腔科学 | 135篇 |
临床医学 | 334篇 |
内科学 | 708篇 |
皮肤病学 | 138篇 |
神经病学 | 605篇 |
特种医学 | 138篇 |
外科学 | 401篇 |
综合类 | 22篇 |
一般理论 | 2篇 |
预防医学 | 219篇 |
眼科学 | 67篇 |
药学 | 293篇 |
中国医学 | 2篇 |
肿瘤学 | 256篇 |
出版年
2024年 | 2篇 |
2023年 | 38篇 |
2022年 | 52篇 |
2021年 | 96篇 |
2020年 | 81篇 |
2019年 | 112篇 |
2018年 | 98篇 |
2017年 | 72篇 |
2016年 | 110篇 |
2015年 | 128篇 |
2014年 | 165篇 |
2013年 | 165篇 |
2012年 | 307篇 |
2011年 | 331篇 |
2010年 | 192篇 |
2009年 | 189篇 |
2008年 | 311篇 |
2007年 | 293篇 |
2006年 | 282篇 |
2005年 | 245篇 |
2004年 | 281篇 |
2003年 | 240篇 |
2002年 | 211篇 |
2001年 | 22篇 |
2000年 | 25篇 |
1999年 | 36篇 |
1998年 | 40篇 |
1997年 | 34篇 |
1996年 | 26篇 |
1995年 | 23篇 |
1994年 | 28篇 |
1993年 | 20篇 |
1992年 | 12篇 |
1991年 | 10篇 |
1990年 | 4篇 |
1986年 | 6篇 |
1985年 | 3篇 |
1984年 | 2篇 |
1982年 | 2篇 |
1978年 | 1篇 |
1977年 | 1篇 |
1976年 | 2篇 |
1975年 | 1篇 |
1974年 | 1篇 |
1971年 | 1篇 |
1969年 | 1篇 |
1968年 | 1篇 |
1960年 | 1篇 |
1947年 | 1篇 |
1946年 | 1篇 |
排序方式: 共有4311条查询结果,搜索用时 15 毫秒
51.
Limperger Verena Kenet Gili Kiesau Bettina Köther Max Schmeiser Malin Langer Florian Juhl David Shneyder Maria Franke Andre Klostermeier Ulrich K. Mesters Rolf Rühle Frank Stoll Monika Steppat Dagmar Kowalski Dorothee Rocke Angela Kuta Piotr Bajorat Tido Torge Antje Neuner Bruno Junker Ralf Nowak-Göttl Ulrike 《Journal of thrombosis and thrombolysis》2021,51(2):494-501
Journal of Thrombosis and Thrombolysis - The role of the A>G polymorphism at position 19911 in the prothrombin gene (factor [F] 2 at rs3136516) as a risk factor for venous thromboembolism... 相似文献
52.
Atila Cihan Monnerat Sophie Urwyler Sandrine Andrea Refardt Julie Winzeler Bettina Christ-Crain Mirjam 《Pituitary》2022,25(4):636-644
Pituitary - Non-osmotic stimulation tests using glucagon, arginine, or macimorelin were recently evaluated for their ability to assess posterior pituitary function. Glucagon and arginine, but not... 相似文献
53.
Christian-Hendrik Heeger MD Jan-Eric Bohnen MD Sorin Popescu Roza Meyer-Saraei PhD Thomas Fink MD Vanessa Sciacca Bettina Kirstein MD Sascha Hatahet MD Anna Traub MD Lisbeth D. Lopez MD Michael Schlüter Karl-Heinz Kuck MD Charlotte Eitel MD Julia Vogler MD Roland Richard Tilz MD 《Journal of cardiovascular electrophysiology》2021,32(6):1553-1560
54.
Berenguer B Alarcón De La Lastra C Motilva V La Casa C Herrerias JM Pozo D Calero MJ 《Digestive diseases and sciences》2004,49(6):937-947
Selective COX-2 inhibitors have been shown to produce fewer gastrointestinal adverse reactions than classical NSAIDs. Nevertheless, these new agents may worsen and delay the healing of experimentally induced gastric ulcers in animals. In this study, we compared the effects of a selective COX-2 inhibitor (celecoxib), a preferential COX-1 inhibitor (piroxicam), and a nonnarcotic analgesic (metamizol) on normal gastric mucosa of rats and, on the other hand, in a setting of preexisting acute gastric lesions induced by 0.6 N hydrochloric acid. Under normal conditions, only piroxicam produced appreciable gastric lesions. However, after acid challenge the three assayed drugs induced significant macroscopic and microscopic damage. Myeloperoxidase activity as an index of neutrophil infiltration was elevated with celecoxib and piroxicam on normal gastric mucosa. On inflamed mucosa, celecoxib augmented enzymatic activity at the lower dose, which was parallelled by an increase in the interleukin 1beta level. Acid instillaton produced a significant rise in PGE2 content at 7 hr. Drug treatment after acid challenge decreased prostaglandin values in all cases, although to a lesser extent than after single drug dose administration. COX-2 mRNA expression was visible 1 hr after acid application, whereas COX-2 protein could only be detected at 7 hr. Piroxicam increased both expression levels. All NSAIDs enhanced transforming growth factor alpha and epidermal growth factor receptor immunoreactivity around the acid-induced lesions. It is concluded that selective COX-2 inhibitors, like conventional NSAIDs, impair the healing of gastric damage, and therefore special attention should be paid in patients with gastric pathologies. 相似文献
55.
Novel approach to the newborn with hypoplastic left heart syndrome and intact atrial septum. 总被引:1,自引:0,他引:1
Alexander J Javois Andrew H Van Bergen Bettina F Cuneo Tarek S Husayni 《Catheterization and cardiovascular interventions》2005,66(2):268-272
A prenatally diagnosed fetus with hypoplastic left heart syndrome and intact atrial septum was delivered in the cardiac catheterization suite. Using radio frequency energy, a transseptal perforation of the thickened and intact atrial septum was immediately performed following transcatheter cannulation of the right atrium via the umbilical vein. Serial cutting balloon septostomies followed by static balloon septostomies resulted in effective left atrial decompression, atrial mixing, and optimal pulmonary and systemic perfusion. The child is now thriving after both stage I Norwood and bidirectional Glenn procedures. 相似文献
56.
Effects of chitosan and bioactive glass modifications of knitted and rolled polylactide‐based 96/4 L/D scaffolds on chondrogenic differentiation of adipose stem cells 下载免费PDF全文
Katja Ahtiainen Laura Sippola Manu Nurminen Bettina Mannerström Suvi Haimi Riitta Suuronen Jari Hyttinen Timo Ylikomi Minna Kellomäki Susanna Miettinen 《Journal of tissue engineering and regenerative medicine》2015,9(1):55-65
The performance of biodegradable knitted and rolled 3‐dimensional (3D) polylactide‐based 96/4 scaffolds modified with bioactive glass (BaG) 13‐93, chitosan and both was compared with regard to the viability, proliferation and chondrogenic differentiation of rabbit adipose stem cells (ASCs). Scaffold porosities were determined by micro‐computed tomography (μCT). Water absorption and degradation of scaffolds were studied during 28‐day hydrolysis in Tris‐buffer. Viability, number and differentiation of ASCs in PLA96/4 scaffolds were examined in vitro. The dimensions of the scaffolds were maintained during hydrolysis and mass loss was detected only in the BaG13‐93 containing scaffolds. ASCs adhered and proliferated on each scaffold type. Cell aggregation and expression of chondral matrix components improved in all scaffold types in chondrogenic medium. Signs of hypertrophy were detected in the modified scaffolds but not in the plain PLA96/4 scaffold. Chondrogenic differentiation was most enhanced in the presence of chitosan. These findings indicate that the plain P scaffold provided a good 3D‐matrix for ASC proliferation whereas the addition of chitosan to the PLA96/4 scaffold induced chondrogenic differentiation independent of the medium. Accordingly, a PLA96/4 scaffold modified by chitosan could provide a functional and bioactive basis for tissue‐engineered chondral implants. Copyright © 2012 John Wiley & Sons, Ltd. 相似文献
57.
58.
Hitomi Hosoya Andrey S. Dobroff Wouter H. P. Driessen Vittorio Cristini Lina M. Brinker Fernanda I. Staquicini Marina Cardó-Vila Sara D’Angelo Fortunato Ferrara Bettina Proneth Yu-Shen Lin Darren R. Dunphy Prashant Dogra Marites P. Melancon R. Jason Stafford Kohei Miyazono Juri G. Gelovani Kazunori Kataoka C. Jeffrey Brinker Richard L. Sidman Wadih Arap Renata Pasqualini 《Proceedings of the National Academy of Sciences of the United States of America》2016,113(7):1877-1882
A major challenge of targeted molecular imaging and drug delivery in cancer is establishing a functional combination of ligand-directed cargo with a triggered release system. Here we develop a hydrogel-based nanotechnology platform that integrates tumor targeting, photon-to-heat conversion, and triggered drug delivery within a single nanostructure to enable multimodal imaging and controlled release of therapeutic cargo. In proof-of-concept experiments, we show a broad range of ligand peptide-based applications with phage particles, heat-sensitive liposomes, or mesoporous silica nanoparticles that self-assemble into a hydrogel for tumor-targeted drug delivery. Because nanoparticles pack densely within the nanocarrier, their surface plasmon resonance shifts to near-infrared, thereby enabling a laser-mediated photothermal mechanism of cargo release. We demonstrate both noninvasive imaging and targeted drug delivery in preclinical mouse models of breast and prostate cancer. Finally, we applied mathematical modeling to predict and confirm tumor targeting and drug delivery. These results are meaningful steps toward the design and initial translation of an enabling nanotechnology platform with potential for broad clinical applications.A long-term goal in contemporary cancer nanomedicine has been to design and generate drug delivery systems that improve the narrow therapeutic window associated with conventional chemotherapeutics (1, 2). Conceptually, several nanotechnology-based entity candidates, including protocells (3), biosynthetic nanoparticles (NPs), viruses, and liposome-based nanoparticles, could be targeted for active delivery through a defined cell surface ligand receptor system and/or physically triggered for finely tuned cargo release (2, 4, 5).Numerous efforts have been made to functionalize NPs by combining them with antibodies, aptamers, peptides, vitamins, or carbohydrates (6–8), but the majority of studies involve untargeted nanoplatforms (4, 9). In practice, targeting NPs is far from trivial, and ongoing challenges include synthesis and purification, selection of an appropriate ligand receptor, and specific composition for NP conjugation. Even the conjugation reaction itself may alter the binding of the tumor-targeting moiety to its receptor through conformational changes, steric freedom restriction, or orientation distortion (10, 11). Unfortunately, the cost-to-benefit ratio of these modifications often elevate the complexity of the NP synthesis, complicating regulatory hurdles because of formulations that are heterogeneous or difficult to reproduce (10, 12, 13).To minimize such drawbacks, NPs can be functionalized via virus-based nanoplatforms as an alternative for targeted cargo delivery (14–16). In particular, filamentous bacteriophage (phage)—a prokaryotic virus—is an attractive candidate to develop a bionanomedicine for cancer therapeutics because phage particles are cost-effectively produced with biological uniformity, as well as being physically robust and stable under harsh conditions (17). Notably, phage-based nanoplatforms are biocompatible and nonpathogenic with eukaryotic organisms and are able to preserve the desired cell targeting and internalization (18). Moreover, phage particles are ideal for incorporating other NPs, which can be released after reaching the tumor site. An admixture of colloidal gold NP (AuNP) with phage particles spontaneously organizes into hydrogel network-like fractal structures (19, 20). These hydrogel networks offer convenient multifunctional integration within a single entity for tumor targeting, enhanced fluorescence and dark-field microscopy, near-infrared (NIR) photon-to-heat conversion, and surface-enhanced Raman scattering (SERS)-based detection (20, 21).In the present work, we developed a tumor targeting theranostic (meaning a combination of therapeutics and diagnostics) hydrogel-based nanoplatform that enables ligand-directed tumor targeting, multimodal imaging capability, and triggered therapeutic cargo release. Our data suggest that targeted hydrogel photothermal therapy represents a functional theranostic approach (fostering “see and treat, treat and see”) in the diagnosis and management of tumors. 相似文献
59.
60.
Parham Sendi Sarah Drger Bettina Batzer Susanne Walser Marc Dangel Andreas F. Widmer 《Influenza and other respiratory viruses》2020,14(1):72-76
We report an influenza outbreak in a 75‐bed rehabilitation centre and present the detailed microeconomic impact that it had during the season 2016/2017. The direct medical, direct non‐medical and indirect costs were calculated. The outbreak included 18 patients with influenza and 8 contact patients, leading to 86 days with isolation precautions. During the outbreak month, 25 (15%) employees were absent from work for 89 days (mean 3.6 days, SD ± 1.8), and during the entire influenza season 33 for 175 (5.3 ± SD 4.6) days, respectively. The economic burden related to the outbreak was 114 373 CHF (106 890 €, 112 131 $). 相似文献